Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "therapeutic targets"

ResearchRSS4 days ago

Scientists in China use AI to pinpoint new therapeutic targets in PAH

Researchers in China used artificial intelligence to study the genes involved in pulmonary arterial hypertension (PAH), a serious condition where blood vessels in the lungs become narrowed and stiff. They identified two genes called ATP1B1 and HP that appear to be important in causing PAH. These genes could potentially become targets for new treatments in the future.

WHY IT MATTERSIf ATP1B1 and HP prove to be valid therapeutic targets, they could lead to new treatment options for PAH patients who currently have limited medication choices.
👁 Watch this spacepulmonary arterial hypertension

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases